CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FiercePharma
Original article

{"a":[{"_":"CDMO Argonaut sheds life sciences, diagnostics division for undisclosed sum","$":{"href":"/pharma/cdmo-argonaut-sheds-life-sciences-diagnostics-division-undisclosed-sum","hreflang":"en"}}]}

Neutral
AI Analysis

Summary

Argonaut Manufacturing Services has divested its life sciences and diagnostics division to private equity firm 1315 Capital for an undisclosed price. The CDMO specializes in aseptic fill-finish services for injectable biologics.

Importance:3/10
Sentiment:
0.00
CDMOdivestitureaseptic fill-finishbiologicsprivate equity
Related Companies

Read the original article

Published by FiercePharma on September 11, 2026 8:16 AM

Read Original